|
Volumn 21, Issue 2, 2009, Pages 167-174
|
Initial results of bladder preserving approach by chemo-radiotherapy in patients with muscle invading transitional cell carcinoma.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
ARTICLE;
BLADDER TUMOR;
CANCER INVASION;
CLINICAL TRIAL;
FEMALE;
FOLLOW UP;
HUMAN;
MALE;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
MUSCLE TUMOR;
ORGAN PRESERVATION;
PATHOLOGY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
RADIATION DOSE;
SURVIVAL RATE;
TRANSITIONAL CELL CARCINOMA;
TREATMENT OUTCOME;
TUMOR RECURRENCE;
ANTINEOPLASTIC AGENTS;
CARCINOMA, TRANSITIONAL CELL;
CISPLATIN;
COMBINED MODALITY THERAPY;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
MIDDLE AGED;
MUSCLE NEOPLASMS;
NEOPLASM INVASIVENESS;
NEOPLASM RECURRENCE, LOCAL;
ORGAN PRESERVATION;
RADIATION DOSAGE;
SURVIVAL RATE;
TREATMENT OUTCOME;
URINARY BLADDER NEOPLASMS;
|
EID: 79952279140
PISSN: 11100362
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (11)
|
References (0)
|